Page last updated: 2024-09-04

docetaxel anhydrous and Atypical Hemolytic-Uremic Syndrome

docetaxel anhydrous has been researched along with Atypical Hemolytic-Uremic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boito, R; Bova, F; Colombo, AF; Greco, S; LucĂ , R; Rizzuto, G; Sellaro, A1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Atypical Hemolytic-Uremic Syndrome

ArticleYear
[Atypical Hemolitic Uremic Syndrome after administration of Docetaxel].
    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018, Volume: 35, Issue:2

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atypical Hemolytic Uremic Syndrome; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Penile Neoplasms; Plasma; Postoperative Complications; Renal Dialysis; Taxoids

2018